p16(INK4A) adenovirus-mediated gene therapy for human head and neck squamous cell cancer

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1697-1704

  Rocco, James W ^a   Li, Daqing ^a   Liggett Jr , William H ^a   Duan, Ling ^a   Saunders Jr , John K ^a   Sidransky, David ^a   O'Malley Jr , Bert W ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Gene and Molecular Therapy Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P16INK4A;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; FLOW CYTOMETRY; GENE TARGETING; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL CYCLE; CELL DIVISION; GENE VECTOR; GENETICS; HEAD AND NECK TUMOR; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE THERAPY; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; TUMOR CELLS, CULTURED;

EID: 0031594996     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
2. Larson, D. L., Lindberg, R. D., Lane, E., and Goepfert, H. Major complications of radiotherapy in cancer of the oral cavity and oropharynx. Am. J. Surg., 146: 531-536, 1983.
3. American Cancer Society Facts and Figures, Publication No. 93-400. Washington, DC: American Cancer Society, 1993.
4. Merino, O. R., Lindberg, R. D., and Fletcher, G. H. An analysis of distant metastasis from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (Phila.), 40: 147-156, 1977.
5. O'Malley, B. W., Jr., Chen, S. H., Schwartz, M. R., and Woo, S. L. C. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55: 1080-1085, 1995.
6. O'Malley, B. W., Jr., Cope, K. A., Chen, S. H., Li, D., Schwartz, M. R., and Woo, S. L. C. Combination gene therapy for oral cancer in a murine model. Cancer Res., 50: 1737-1741, 1996.
7. Sewell, D. A., Li, D., Duan, L., Schwartz, M. R., and O'Malley, B. W., Jr. Optimizing suicide gene therapy for head and neck cancer. Laryngoscope, 107: 1490-1495, 1997.
8. Liu, T. J., El-Nagger, A. K., Roth, J. A., Zhang, W. W., Goepfert, H., Taylor, D. L., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
9. Clayman, G. L., El-Nagger, A. K., Roth, J. A., Zhang, W. W., Goepfert, H., Taylor, D. L., and Liu, T. J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
10. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, Y. E., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
11. Serrano, M., Gomez-Lahoz, E., Depino, R. A., Beach, D., and Bar-Sagi, D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (Washington DC), 267: 249-252, 1995.
12. Liggett, W. W., Jr., Sewell, D. A., Rocco, J. W., Ahrendt, S. A., Koch, W., and Sidransky, D. p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56: 4119-4123, 1996.
13. Jin, X., Nguyen, D., Zhang, W. W., Kyritsis, A. P., and Roth, J. A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3252, 1995.
14. CDKN4) human prostate cancers. J. Urol., 158: 636-641, 1997.
15. Chintala, S. K., Fueyo, J., Gomez-Manzano, C., Venkaiah, B., Bjerkvig, R., Yung, W., Sawaya, R. Kyritsis, A. P., and Rao, J. S. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene, 15: 2049-2057, 1997.
16. Serrano, M., Hanoi, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
17. Draetta, G. Mammalian G1 cyclins. Curr. Opin. Cell Biol., 6: 842-846, 1994.
18. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
19. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
20. INK4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
21. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell, 41: 521-530, 1995.
22. Graham, F. L., and Prevac, L. Manipulation of adenovirus vectors. In: E. J. Murray (ed.), Methods in Molecular Biology, Gene Transfer and Expression Protocols, pp. 109-128. Totowa, NJ: Humana Press, Inc., 1991.
23. Zhang, W. W., Koch, P. E., and Roth, J. A. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques, 18: 444-447, 1995.
24. Schagger, H., and von Jagow, G. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range of 1 to 100 kDa. Anal. Biochem., 166: 368-379, 1987.
25. INK4A. Cancer Res., 54: 5816-5820, 1994.
26. Li, Y., Nichols, M. A., Shay. J. W., and Xiong, Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res., 54: 6078-6082, 1994.
27. Rofstad, E. K., Radiation biology of human tumor xenografts. Int. J. Radiat. Biol., 56: 573-581, 1989.
28. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.
29. Yoo, G. H., Hong-Ji, X., Brennan, J. A., Westra, W., Hruban, R. H., Koch, W., Benedict, W. F., and Sidransky, D. Infrequent activation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
30. Sellers, W. R., and Kaelin, W. G. Role of retinoblastoma protein in the pathogenesis of human cancer. J. Clin. Oncol., 15: 3301-3312, 1997.
31. Mittal, S. K., Brett, A. J., Prevac, L., and Graham, F. L. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial βgalactosidase genes as reporters. Virology, 210: 226-230, 1995.
32. Fisher, K. J., Choi, H., Burda, J., Chen, S. J., and Wilson, J. M. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology, 217: 11-22, 1996.
33. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med., 3: 313-319, 1997.
34. Brennan, J. A., Mao, L. Hruban, R., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. N. Engl. J. Med., 332: 429-435, 1995.